Article Details
Retrieved on: 2024-06-07 18:16:07
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the development of a new COVID-19 monoclonal antibody, 1301B7, which uses hydrogen bonding to neutralize SARS-CoV-2 variants, including Omicron. This connects to the tags about vaccines and COVID-19, highlighting advancements in immunology and potential treatments for ongoing mutations.
Article found on: www.forbes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here